Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Crum

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Effect of cisplatin upon expression of in vivo immune tumor resistanceE D Crum
Cancer Research|August 1, 1984
Subsets of circulating T-lymphocytes mediating resistance to in vivo growth of a carcinogen-induced syngeneic rat tumorE D Crum
Cancer Research|November 1, 1987
Specific induction of local antitumor effector cells mediated in vivo by the circulating lymphocyte poolE D Crum
International Journal of Cancer|July 15, 1980
Lymphocytes that mediate systemic resistance to in vivo growth of a carcinogen-induced syngeneic tumorE D Crum
Cellular Immunology|April 15, 1983
The subset of T lymphocytes mediating delayed-type hypersensitivity in the ratE D Crum
International Journal of Cancer|November 15, 1977
Induction of tumor resistance with BCG-associated tumor antigenE D Crum, D D McGregor
Immunology|April 1, 1976
Induction of delayed-type hypersensitivity with BCG-associated proteinsE D Crum, D D McGregor
Cancer Research|February 1, 1991
In vivo activity of solid phase interleukin 2E D Crum, D R Kaplan
Immunology|December 1, 1977
Immunity to Trichinella spiralis. I. Transfer of resistance by two classes of lymphocytesE D Crum, D D Despommier, D D McGregor
Medical and Pediatric Oncology|January 1, 1988
Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanineT R Spitzer, H M Lazarus, E D Crum, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Effect of cisplatin upon expression of in vivo immune tumor resistanceE D Crum
Cancer Research|August 1, 1984
Subsets of circulating T-lymphocytes mediating resistance to in vivo growth of a carcinogen-induced syngeneic rat tumorE D Crum
Cancer Research|November 1, 1987
Specific induction of local antitumor effector cells mediated in vivo by the circulating lymphocyte poolE D Crum
International Journal of Cancer|July 15, 1980
Lymphocytes that mediate systemic resistance to in vivo growth of a carcinogen-induced syngeneic tumorE D Crum
Cellular Immunology|April 15, 1983
The subset of T lymphocytes mediating delayed-type hypersensitivity in the ratE D Crum
International Journal of Cancer|November 15, 1977
Induction of tumor resistance with BCG-associated tumor antigenE D Crum, D D McGregor
Immunology|April 1, 1976
Induction of delayed-type hypersensitivity with BCG-associated proteinsE D Crum, D D McGregor
Cancer Research|February 1, 1991
In vivo activity of solid phase interleukin 2E D Crum, D R Kaplan
Immunology|December 1, 1977
Immunity to Trichinella spiralis. I. Transfer of resistance by two classes of lymphocytesE D Crum, D D Despommier, D D McGregor
Medical and Pediatric Oncology|January 1, 1988
Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanineT R Spitzer, H M Lazarus, E D Crum, et al.
Pageof 2